Virus-Inspired Virtue Signaling by Attention Hungry AI Developers
April 22, 2020
An article at HackerNoon describes several uses of AI that have an impact on society—some that went very wrong and some that are going quite right. It ponders “The Future of Artificial Intelligence: To Kill or To Heal?” The article covers the issue of biased AI, using the example of the US criminal justice system. It also discusses the resistance in most countries to governments’ use of facial recognition software. While China’s use of the technology to control its citizens has been largely (and rightly) decried, the write-up asserts it has been very useful in containing the spread of the novel coronavirus in that country. See the article for details. AI has also been helping address the pandemic through the use of machine learning to track disease around the globe. We’re told:
“BlueDot is an AI platform that uses NLP and machine learning to track infectious diseases across the globe. It does this by employing algorithms that rapidly browse a multitude of sources. The algorithms are designed to flag early signs of epidemics. In the last weeks of December 2019, the platform recognized a cluster of ‘unusual pneumonia’ diagnoses in Wuhan, China. A little over a week later, the World Health Organization (WHO) came out with an official statement on the existence of a ‘novel coronavirus’ in a patient in Wuhan. BlueDot isn’t the only AI that can flag areas of concern across thousands of sources. Alibaba, a global E-commerce powerhouse, created StructBERT, which is powered by NLP models. The models are capable of processing viral gene-sequences at a fast rate, as well as screening proteins. Alibaba has put the platform to use in the fight against COVID-19. It is freely available to researchers and scientists who can use the information and technology to speed the development of vaccines.”
Then there is the search for a cure. One recent paper describes a machine learning model from Deargen, a firm out of South Korea. The model has identified four possible antiviral meds that might just mitigate COVID-19. Another paper, this one from Hong Kong’s Insilico Medicine, reveals that firm’s AI platform is busy modeling thousands of novel molecules in the hope of turning up one that can disrupt the virus’ replication.
Keep in mind that there are more AI solutions solving virus problems than DarkCyber can monitor. It is easier to count wonky infection data than get AI to deliver more than lists of probables to investigate.
Cynthia Murrell, April 22, 2020
Comments
-
- Subscribe to Beyond Search
Feature archive
News archive
-
